11/26
02:23 pm
uthr
United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
12:18 pm
uthr
United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base [Yahoo! Finance]
Low
Report
United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base [Yahoo! Finance]
11/20
11:54 pm
uthr
United Therapeutics: Growing Company With Great Franchise In Pulmonary Diseases [Seeking Alpha]
Low
Report
United Therapeutics: Growing Company With Great Franchise In Pulmonary Diseases [Seeking Alpha]
11/20
01:40 pm
uthr
United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
11/19
06:02 am
uthr
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
11/14
01:19 pm
uthr
United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
11/10
02:04 pm
uthr
United Therapeutics Corporation (UTHR) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Low
Report
United Therapeutics Corporation (UTHR) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
11/10
03:16 am
uthr
3 Reasons Investors Love United Therapeutics (UTHR) [Yahoo! Finance]
Low
Report
3 Reasons Investors Love United Therapeutics (UTHR) [Yahoo! Finance]
11/9
01:13 am
uthr
United Therapeutics (NASDAQ:UTHR) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Low
Report
United Therapeutics (NASDAQ:UTHR) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
11/6
01:29 pm
uthr
United Therapeutics (NASDAQ:UTHR) had its price target raised by analysts at UBS Group AG from $580.00 to $600.00. They now have a "buy" rating on the stock.
Low
Report
United Therapeutics (NASDAQ:UTHR) had its price target raised by analysts at UBS Group AG from $580.00 to $600.00. They now have a "buy" rating on the stock.
11/4
12:39 pm
uthr
First clinical trial of pig kidney transplants gets underway [Los Angeles Times (CA)]
Low
Report
First clinical trial of pig kidney transplants gets underway [Los Angeles Times (CA)]
11/4
07:00 am
uthr
United Therapeutics Corporation to Present at Upcoming Investor Conferences
Low
Report
United Therapeutics Corporation to Present at Upcoming Investor Conferences
11/3
07:00 am
uthr
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
Low
Report
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
10/30
06:43 pm
uthr
United Therapeutics (UTHR): Earnings Growth Slows, Reinforcing Cautious Market Narratives Despite High Margins [Yahoo! Finance]
Low
Report
United Therapeutics (UTHR): Earnings Growth Slows, Reinforcing Cautious Market Narratives Despite High Margins [Yahoo! Finance]
10/30
11:04 am
uthr
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/30
11:02 am
uthr
United Therapeutics (NASDAQ:UTHR) had its price target raised by analysts at Wells Fargo & Company from $414.00 to $423.00. They now have an "equal weight" rating on the stock.
Low
Report
United Therapeutics (NASDAQ:UTHR) had its price target raised by analysts at Wells Fargo & Company from $414.00 to $423.00. They now have an "equal weight" rating on the stock.
10/30
10:59 am
uthr
United Therapeutics (NASDAQ:UTHR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
United Therapeutics (NASDAQ:UTHR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
10/29
08:11 pm
uthr
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
10/29
03:58 pm
uthr
United Therapeutics (NASDAQ:UTHR) was given a new $447.00 price target on by analysts at Morgan Stanley.
Low
Report
United Therapeutics (NASDAQ:UTHR) was given a new $447.00 price target on by analysts at Morgan Stanley.
10/29
06:30 am
uthr
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
High
Report
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
10/20
08:14 am
uthr
United Therapeutics (NASDAQ:UTHR) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating and a $414.00 price target on the stock.
Low
Report
United Therapeutics (NASDAQ:UTHR) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating and a $414.00 price target on the stock.
10/18
10:11 pm
uthr
Why The Narrative Around United Therapeutics Is Shifting After Major Clinical and Pipeline Updates [Yahoo! Finance]
Low
Report
Why The Narrative Around United Therapeutics Is Shifting After Major Clinical and Pipeline Updates [Yahoo! Finance]
10/16
04:07 pm
uthr
Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case [Yahoo! Finance]
Low
Report
Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case [Yahoo! Finance]
10/15
07:00 am
uthr
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
Low
Report
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
10/13
07:11 am
uthr
United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting [Yahoo! Finance]
Low
Report
United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting [Yahoo! Finance]